Emtricitabine, Rilpivirine and Tenofovir Disoproxil
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
NADAC/unit
N/A
No Shortage
Emtricitabine, Rilpivirine and Tenofovir Disoproxil blocks HIV replication by inhibiting reverse transcriptase.
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.